Wednesday morning Monsanto announced they were positioning to sell their ownership of POSILAC bovine somatotropin during the next few months. Since first used in 1994, POSILAC has become the country's leading dairy supplement. It increases dairy cow's production safely, helping increase efficiency and sustainability of dairy operations. A recent study by Cornell University also showed that its use can help lower the impact dairy operations have on the environment.
"While POSILAC is a strong product for the business, we believe repositioning the business with a strategic owner will allow Monsanto to focus on the growth of its core seeds and traits business while ensuring that loyal dairy farmers continue to receive the value of POSILAC in their operations," said Carl Casale, Monsanto's Executive Vice-President of Strategy and Operations.